Cargando…
Leukobiopsy – A Possible New Liquid Biopsy Platform for Detecting Oncogenic Mutations
Detection of unique oncogenic alterations encoded by the sequence or biochemical modification in cancer-associated transforming macromolecules has revolutionized diagnosis, classification and management of human cancers. While these signatures were traditionally regarded as largely intracellular and...
Autores principales: | Chennakrishnaiah, Shilpa, Tsering, Thupten, Aprikian, Saro, Rak, Janusz |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6993065/ https://www.ncbi.nlm.nih.gov/pubmed/32038264 http://dx.doi.org/10.3389/fphar.2019.01608 |
Ejemplares similares
-
Extracellular vesicles from genetically unstable, oncogene-driven cancer cells trigger micronuclei formation in endothelial cells
por: Chennakrishnaiah, Shilpa, et al.
Publicado: (2020) -
EV‐ADD, a database for EV‐associated DNA in human liquid biopsy samples
por: Tsering, Thupten, et al.
Publicado: (2022) -
Barriers to horizontal cell transformation by extracellular vesicles containing oncogenic H-ras
por: Lee, Tae Hoon, et al.
Publicado: (2016) -
Circulating tumor DNA tracking through driver mutations as a liquid biopsy-based biomarker for uveal melanoma
por: Bustamante, Prisca, et al.
Publicado: (2021) -
Beyond Circulating Tumor Cell Enumeration: Cell-Based Liquid Biopsy to Assess Protein Biomarkers and Cancer Genomics Using the RareCyte(®) Platform
por: Kaldjian, Eric P., et al.
Publicado: (2022)